November 10–11 | London Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to speak at the Financial Times Global Healthcare Summit in London. (IMAGE)
Caption
On November 10 at 13:30 PM, he will deliver an address and join the panel discussion titled "Longevity medicine — a new scientific frontier and biotech category?"
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content